Table 2.
Effects of interventions on mean blood pressure across the whole trial, N = 975 participants (13,925 study visits for systolic blood pressure and 12,924 visits for diastolic blood pressure)
Change in systolic blood pressure, mm Hg | Change in diastolic blood pressure, mm Hg | |||
---|---|---|---|---|
β (95% CI) | P | β (95% CI) | P | |
All groups | ||||
Usual care | Reference | — | Reference | — |
Weight loss | −2.46 (−4.55, −0.37) | 0.021 | −0.98 (−2.50, 0.54) | 0.21 |
Sodium reduction | −1.79 (−3.44, −0.14) | 0.034 | −0.50 (−1.50, 0.50) | 0.33 |
Weight loss and sodium reduction | −4.33 (−6.48, −2.17) | <0.001 | −2.47 (−3.88, −1.06) | 0.001 |
Factorial design—weight loss | ||||
No weight lossa | Reference | — | Reference | — |
Weight loss | −2.49 (−4.00, −0.98) | 0.001 | −1.48 (−2.51, −0.44) | 0.005 |
Factorial design—sodium reduction | ||||
No sodium reductiona | Reference | — | Reference | — |
Sodium reduction | −1.81 (−3.20, −0.42) | 0.011 | −0.79 (−1.68, 0.09) | 0.08 |
Change in follow-up blood pressure was modeled using a generalized estimating equation adjusted for baseline obesity status, field center, and baseline systolic or diastolic blood pressure. Interaction terms between weight loss and sodium reduction were nonsignificant. Abbreviation: CI, confidence interval.
aNo weight loss includes usual care and sodium reduction. No sodium reduction includes usual care and weight loss.